ANG Lifesciences

ANG Lifesciences

30.91
-0.69
(-2.18%)
hide
Key Fundamentals
Add Ratio
Market Cap
41.30 Cr
EPS
-9.42
PE Ratio
-3.56
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
50.50
52 Week Low
21.03
PB Ratio
0.68
Debt to Equity
1.11
Forecast For
Actual

Company News

View All News
Caret
neutral
ANG Lifesciences Reports Loss of ₹78.73 Lakhs in Q1 FY2026Aug 14, 2025
ANG Lifesciences India Limited reported a standalone net loss of ₹78.73 lakhs for the quarter ended June 30, 2025, compared to a loss of ₹276.53 lakhs in the same quarter last year. Revenue from operations increased to ₹2,453.18 lakhs from ₹1,617.67 lakhs year-over-year. On a consolidated basis, the company posted a net loss of ₹200.62 lakhs versus ₹307.30 lakhs in the previous year quarter. The pharmaceutical manufacturer operates in two segments - pharmaceuticals and printing & packaging. The Board of Directors approved these unaudited financial results on August 14, 2025.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
-35.35 %
Net Income Growth
22.77 %
Cash Flow Change
97.26 %
ROE
45.86 %
ROCE
-3,352.00 %
EBITDA Margin (Avg.)
-103.69 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
32
36
120
90
50
96
74
60
47
49
57
34
19
38
20
33
25
18
25
Expenses
31
33
90
70
44
83
62
50
44
50
50
32
21
36
20
31
27
18
24
EBITDA
2
4
30
20
6
13
12
10
3
-1
7
2
-2
2
-0
3
-2
-0
1
Operating Profit %
5 %
9 %
25 %
22 %
11 %
13 %
16 %
16 %
6 %
-26 %
12 %
5 %
-10 %
4 %
-9 %
7 %
-9 %
-4 %
3 %
Depreciation
0
0
1
1
2
3
2
2
2
3
2
2
2
2
2
2
2
1
2
Interest
1
1
1
2
2
4
3
3
4
2
2
2
3
4
2
2
2
2
2
Profit Before Tax
1
2
28
17
2
7
7
4
-3
-6
2
-3
-6
-4
-4
-1
-6
-4
-3
Tax
0
1
8
4
1
2
3
2
-1
-1
1
-0
-0
-0
-1
1
-1
-2
-1
Net Profit
0
1
20
13
1
5
4
3
-2
-5
2
-2
-6
-4
-3
-2
-5
-2
-2
EPS in ₹
0.42
2.30
38.66
12.41
1.29
5.16
3.99
2.20
-1.36
-3.63
1.41
-1.74
-4.52
-2.75
-2.35
-1.53
-3.98
-1.56
-1.52

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
291
278
242
230
Fixed Assets
93
88
58
57
Current Assets
193
183
173
161
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
198
190
184
172
Total Liabilities
291
278
242
230
Current Liabilities
166
162
145
143
Non Current Liabilities
41
29
22
22
Total Equity
84
86
76
64
Reserve & Surplus
69
69
59
46
Share Capital
10
13
13
13

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
Investing Activities
-44
-9
20
-2
Operating Activities
25
26
-10
-0
Financing Activities
20
-17
-10
2

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
71.01 %
71.07 %
71.09 %
71.14 %
71.15 %
71.15 %
71.15 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.94 %
25.53 %
26.62 %
25.87 %
25.66 %
25.76 %
25.56 %
26.13 %
26.23 %
26.09 %
25.29 %
25.62 %
25.48 %
25.45 %
25.92 %
26.11 %
26.11 %
Others
9.05 %
3.40 %
2.29 %
2.99 %
3.20 %
3.09 %
3.30 %
3.27 %
3.16 %
3.31 %
4.11 %
3.78 %
3.92 %
3.95 %
3.48 %
3.29 %
3.29 %
No of Share Holders
0
328
323
2,522
4,259
5,215
6,939
7,163
7,305
7,055
6,918
6,868
6,631
6,468
6,517
6,508
6,400

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.33 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 May 2016 CHANGE OF NAME Change Of Name
NA
18 May 2016 0.00 0.00
BONUS Bonus
1:1
22 Sept 2021 258.12 0.00
04 Nov 2021 DIVIDEND Dividend
₹ 1.00 /share
02 Nov 2021 374.80 553.56
14 Jul 2022 BONUS Bonus
1:4
13 Jul 2022 145.32 197.70
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 55.70 50.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 46.81 44.92
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 41.14 38.74
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 31.29 29.64
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 30.06 28.88
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 32.67 32.12

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Appoitment Of Secretarial AuditorSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 24, 2025
Clarification On Price MovementSep 12, 2025
Clarification Sought from ANG Lifesciences India LtdSep 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Notice Of 19Th AGM Of The Company Scheduled To Be Held On 30Th September 2025Sep 06, 2025
Intimation Of Book ClosureSep 06, 2025
19Th Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday The 30Th September 2025 At 11:30 AM Through Video Conference (VC) / Other Audio Visual Means (OAVM)Sep 06, 2025
Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGMSep 06, 2025
Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025.Aug 14, 2025
Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2025Aug 14, 2025
Board Meeting Intimation for Conducting Board Meeting To Consider And Approve Unaudited Standalone & Consolidated Financial Results For The First Quarter Ended 30Th June 2025.Aug 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 16, 2025
Closure of Trading WindowJun 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 12, 2025
Financial Year Results For The Year Ended 31.03.2025May 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 May 22, 2025
Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC) Apr 24, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2025
Closure of Trading WindowApr 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 20, 2025
Appointment of Company Secretary and Compliance OfficerMar 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Outcome for Board Meeting Outcome For SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Declaring Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Financial Results For Quarter And Half Year Ended 30.09.2024.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2024Nov 14, 2024
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015Nov 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Scrutinizer Report And Evoting Result For AGM 30.09.2024 Of ANG Lifesciences India LimitedOct 02, 2024
Disclosure under Regulation 30A of LODROct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2024
Closure of Trading WindowSep 25, 2024
Reg. 34 (1) Annual Report.Sep 07, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 07, 2024
Book Closure For 18Th Annual General MeetingSep 07, 2024
Notice Of AGM For FY 2023-24Sep 07, 2024
Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024Aug 14, 2024

Technical Indicators

RSI(14)
Neutral
44.22
ATR(14)
Less Volatile
1.99
STOCH(9,6)
Neutral
23.71
STOCH RSI(14)
Oversold
9.45
MACD(12,26)
Bearish
-0.55
ADX(14)
Weak Trend
18.23
UO(9)
Bearish
38.09
ROC(12)
Downtrend And Accelerating
-8.19
WillR(14)
Neutral
-77.16